Insomnia therapeutics Market 2019 size, Investment Share, Comprehensive Analysis, Demand, Development Strategy, Future plans and Global Industry Growth with High CAGR by Forecast to 2026
Insomnia is a difficulty in falling asleep or staying asleep, even when a person has the chance to do so. People with insomnia can feel dissatisfied with their sleep or experience low energy fatigue, mood disturbance, difficulty in concentration, or decreased performance at school or workplace. There are various factors responsible for this condition including age, stress associated with job, financial, family, and medical conditions. Moreover, high consumption of alcohol, caffeine, nicotine can lead to insomnia.
For Any Queries Get Solutions With PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/958
On the basis of duration, insomnia is categorized into transient and chronic insomnia. Transient insomnia lasts for a single night to few weeks or months and is an adaptive response to aforementioned challenges. On the contrary, chronic insomnia is more complex, which results from combination of factors mentioned above and lasts for longer period of time. There are carious typos treatment options available for insomnia such as prescription medication or over the counter sleep aid such as natrol melatonin and unisom sleep gel help people to fall asleep with minimum side effects. According to a study by University of Laval, 2011, about 40 % of the adult Canadian are experiencing one or more symptoms of insomnia. Further, a latest research reported in Nature, 2017, stated that insomnia increases the risk in women to deliver premature babies by 30%. Increase in incidence of insomnia across the globe will propel the global insomnia therapeutics market growth.
Global Insomnia therapeutics Market Taxonomy
By Drug Class
- Non benzodiazepines
By Distribution Channel
- Retail & Hospital Pharmacies
- Online Pharmacies
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/958
Market Dynamics- Drivers
New improved medication with lesser side effects to drive the global insomnia therapeutics market growth globally
Innovation of new enhance medications is expected to drive growth of the global insomnia therapeutics market during the forecast period. Benzodiazepines (BZP) such as temazepam and diazepam are commonly prescribed medications for insomnia. Although these medications are effective, extended use of these drugs may lead to cognitive impairment. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period.
Intermezzo (2014), is used in small doses and administered under the tongue for faster absorption. In 2014, Tesimelton received the U.S. Food and Drug Administration (FDA) approval, making it\ the only U.S. FDA-approved drug Non-24-Hour Sleep-Wake Rhythm Disorder, which lacks abuse potential. Hence, these products are expected to drive the global insomnia therapeutics market over the forecast period.
Moreover, increasing awareness and treatment seeking rates for insomnia are expected drive growth of the market over the forecast period.
Market Dynamics- Restraints
However, the loss of exclusivity of the drugs led the market more generalization is creating a competitive environment for new entrants, which in turn, is expected to restrain growth of the market in the near future. For instance, non-benzodiazepines and low dose sedating anti-depressants, still considered as a first line of medication for the insomnia, are facing stiff competition from the generics.
According to a report by Sleep Research Society, 2012, 20% of the general adult population in Canada and U.S is suffering from insomnia and this number is expected to increase in the near future. Problems like daytime sleepiness, and fatigue is affecting larger number of population and imposing a considerable burden on these regions. These factors all together will boost the global insomnia therapeutics market growth in the future period.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/insomnia-therapeutics-market-958
Devices would have a negative impact on the global insomnia therapeutics market
Rapid entry of new players and new devices for insomnia will boost the market over the forecast period. The U.S. FDA approved new device Cerêve Sleep System for insomnia in 2016 this device is used to reduce latency to stage 1 and stage 2 sleep by keeping the forehead cool. Major players in the global insomnia therapeutics market are GlaxoSmithKline plc, UCB Group, Otsuka Holdings Co., Ligand Pharmaceuticals Incorporated, Axxonis Pharma AG, Kyowa Hakko Kirin Co. Ltd., National Institute of Neurological Disorders and Stroke, Jazz Pharmaceuticals, Inc. Ltd., Omeros Corporation, and Manhattan Pharmaceuticals, Inc.About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire